Yarbrough Capital, LLC Glaukos Corp Transaction History
Yarbrough Capital, LLC
- $2.44 Billion
- Q3 2024
A detailed history of Yarbrough Capital, LLC transactions in Glaukos Corp stock. As of the latest transaction made, Yarbrough Capital, LLC holds 4,728 shares of GKOS stock, worth $713,360. This represents 0.03% of its overall portfolio holdings.
Number of Shares
4,728
Previous 4,728
-0.0%
Holding current value
$713,360
Previous $559,000
10.02%
% of portfolio
0.03%
Previous 0.02%
Shares
1 transactions
Others Institutions Holding GKOS
# of Institutions
341Shares Held
46.8MCall Options Held
132KPut Options Held
188K-
Black Rock Inc. New York, NY8.04MShares$1.21 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.87MShares$886 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA2.18MShares$329 Million0.05% of portfolio
-
State Street Corp Boston, MA1.95MShares$295 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.64MShares$247 Million0.06% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $7.18B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...